Amazon.com, Inc. (NASDAQ:AMZN) launching new pickup option called “Counter” with RiteAid

Amazon.com, Inc. (NASDAQ:AMZN) launching a new pickup option called “Counter” with RiteAid. The service enables customers to pickup packages at RiteAid stores. Yahoo Finance’s Melody Hahm joins Seana Smith.

Amazon.com, Inc. (NASDAQ:AMZN), a Services sector firm, traded 2.14 Million shares in last trading session with closing price of $1904.28 per share. Company gross margin stands at 41.10% whereas its return on investment (ROI) is 11.90%. Stock value has moved between $1304.3 – 2047.61 in last one year. Analyst’s mean target price for Amazon.com, Inc. (NASDAQ:AMZN) is $2246.75 while analysts mean recommendation is 1.70. AMZN EPS growth this year is 335.70%. 

On last trading day, NRG Energy, Inc. (NYSE:NRG) shares closed at $34.03 per share. NRG market capitalization is 9057.76 with beta of 0.83. Analyst’s mean target price for NRG Energy, Inc. (NYSE:NRG) is $47.09 whereas analysts mean recommendation is 1.90. Its weekly performance is -2.88% while year to date (YTD) performance is -14.07%. 

In last session Vistra Energy Corp. (NYSE:VST) traded 9.46 Million shares and was closed at $22.24. Analyst’s mean target price for VST is $33.50 while analysts mean recommendation is 1.80. Company is -20.17% away from its 52 week high and is moving 6.74% ahead of its 52 week low. VST return on assets is 1.80%. Vistra Energy Corp. (NYSE:VST) quarterly performance is -13.80% while its price to sale ratio is 0.95. 

Halliburton Company (NYSE:HAL), a Basic Materials sector firm, traded 9.89 Million shares on last trading day with closing price of $22.73 per share. Company gross margin stands at 11.60% whereas its return on investment (ROI) is 11.40%. Stock value has moved between $21.05 – 47.35 in last one year. Analyst’s mean target price for Halliburton Company (NYSE:HAL) is $38.17 while analysts mean recommendation is 1.80. HAL EPS growth this year is 389.60%. 

READ  Apple Trying To Convince It Fans-Base About iPhone Triple-Camera Capabilities

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Read previous post:
FDA granted approval Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for Soliris

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has been granted approval by the Food and Drug Administration for Soliris. Soliris (eculizumab) is an injection for intravenous use...

Close